{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:29:11Z","timestamp":1793647751550,"version":"4.5.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014042","name":"US Department of Defense Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["RA230062"],"award-info":[{"award-number":["RA230062"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014042","name":"US Department of Defense Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["KC200096P1"],"award-info":[{"award-number":["KC200096P1"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002163","name":"Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002163","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA288448"],"award-info":[{"award-number":["R37CA288448"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012287","name":"Andrew Sabin Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 TR0045906"],"award-info":[{"award-number":["UM1 TR0045906"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1UL1TR003167"],"award-info":[{"award-number":["1UL1TR003167"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1UL1TR003167"],"award-info":[{"award-number":["1UL1TR003167"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 TR0045906"],"award-info":[{"award-number":["UM1 TR0045906"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003064","name":"Kidney Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xcrm.2025.102423","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:14Z","timestamp":1761856214000},"page":"102423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-8308","authenticated-orcid":false,"given":"Pavlos","family":"Msaouel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar M.","family":"Tannir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita D.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menuka","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannicola","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul A.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis R.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Shamsutdinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalida M.","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Knipper-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Berlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayla","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danil","family":"Stupichev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Kryukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suren","family":"Davitavyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Novokreshchenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Lebedev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kurpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Kravets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitrii","family":"Belousov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bagaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Kushnarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102423_bib1","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-17-3296","article-title":"A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma","volume":"24","author":"Msaouel","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102423_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2018.09.005","article-title":"Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma","volume":"17","author":"Msaouel","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.xcrm.2025.102423_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.euo.2024.07.002","article-title":"Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients","volume":"8","author":"Lebenthal","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2020.04.002","article-title":"Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma","volume":"37","author":"Msaouel","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102423_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209639120","article-title":"SMARCB1 regulates the hypoxic stress response in sickle cell trait","volume":"120","author":"Soeung","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102423_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236022","article-title":"Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies","volume":"13","author":"Shapiro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2025.102423_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.hoc.2023.04.019","article-title":"Renal Cell Carcinoma of Variant Histology: Biology and Therapies","volume":"37","author":"Msaouel","year":"2023","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.xcrm.2025.102423_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153806","article-title":"A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma","volume":"15","author":"Nze","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2025.102423_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bju.13705","article-title":"Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study","volume":"120","author":"Shah","year":"2017","journal-title":"BJU Int."},{"key":"10.1016\/j.xcrm.2025.102423_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ccell.2022.07.006","article-title":"Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes","volume":"40","author":"Zaitsev","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102423_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.23.02005","article-title":"Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial","volume":"42","author":"Meric-Bernstam","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib12","doi-asserted-by":"crossref","first-page":"E172","DOI":"10.5489\/cuaj.2373","article-title":"Clinical outcome and prognostic factors in renal medullary carcinoma: A pooled analysis from 18 years of medical literature","volume":"9","author":"Iacovelli","year":"2015","journal-title":"Can. Urol. Assoc. J."},{"key":"10.1016\/j.xcrm.2025.102423_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41379-019-0273-1","article-title":"Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases","volume":"32","author":"Jia","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.xcrm.2025.102423_bib14","doi-asserted-by":"crossref","first-page":"e987","DOI":"10.1016\/j.clgc.2017.04.012","article-title":"Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes","volume":"15","author":"Carlo","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.xcrm.2025.102423_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.eururo.2015.09.027","article-title":"Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas","volume":"69","author":"Calderaro","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.xcrm.2025.102423_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.kint.2021.03.011","article-title":"From kidney injury to kidney cancer","volume":"100","author":"Peired","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.xcrm.2025.102423_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144108","article-title":"Deletion of Lats1\/2 in adult kidney epithelia leads to renal cell carcinoma","volume":"131","author":"Carter","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102423_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41467-017-00346-5","article-title":"Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development","volume":"8","author":"Vitte","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102423_bib19","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.3390\/curroncol30030255","article-title":"Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2","volume":"30","author":"Sarkar","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","article-title":"CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma","volume":"14","author":"Pal","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102423_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.910147","article-title":"Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma","volume":"12","author":"Tourigny","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/oncolo\/oyac263","article-title":"Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities","volume":"28","author":"Mahmoud","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.xcrm.2025.102423_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7534","article-title":"A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer","volume":"11","author":"Crawford","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102423_bib24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1158\/1078-0432.CCR-24-3324","article-title":"CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation","volume":"31","author":"Grimm","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102423_bib25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10637-022-01276-w","article-title":"A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors","volume":"40","author":"Adra","year":"2022","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.xcrm.2025.102423_bib26","doi-asserted-by":"crossref","first-page":"TPS3166","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS3166","article-title":"A phase 1, first-in-human study of CUSP06, a cadherin-6 (CDH6) -directed antibody-drug conjugate, in patients with platinum-refractory\/resistant ovarian cancer and other advanced solid tumors","volume":"42","author":"Spira","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib27","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMoa2307980","article-title":"Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer","volume":"389","author":"Ahn","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102423_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg9721","article-title":"EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102423_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/10781552251316433","article-title":"Targeted therapy in TNBC: Exploring the role of antibody-drug conjugates with a focus on sacituzumab govitecan","volume":"31","author":"Siddiqui","year":"2025","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.xcrm.2025.102423_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.breast.2022.10.007","article-title":"Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer","volume":"66","author":"Shastry","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.xcrm.2025.102423_bib31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102423_bib32","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/bph.16252","article-title":"Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics","volume":"180","author":"Wang","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102423_bib33","doi-asserted-by":"crossref","first-page":"858","DOI":"10.20517\/cdr.2023.89","article-title":"Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma","volume":"6","author":"Sweeney","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.xcrm.2025.102423_bib34","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/j.clgc.2021.08.007","article-title":"Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma","volume":"19","author":"Wilson","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.xcrm.2025.102423_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-med-070623-045906","article-title":"CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond","volume":"76","author":"Zang","year":"2025","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xcrm.2025.102423_bib36","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-24-0703","article-title":"Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma","author":"Zacharias","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2025.102423_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2174\/1568009618666180102102311","article-title":"Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update","volume":"18","author":"Eyvazi","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.xcrm.2025.102423_bib38","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/ncomms2992","article-title":"Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells","volume":"4","author":"Ben-David","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102423_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/CCO.0000000000001129","article-title":"Novel therapeutics in refractory germ cell tumors","volume":"37","author":"Richardson","year":"2025","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib40","doi-asserted-by":"crossref","first-page":"TPS4627","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS4627","volume":"42","author":"Kydd","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s42003-024-06020-z","article-title":"Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data","volume":"7","author":"Kotlov","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2025.102423_bib42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.euf.2016.08.005","article-title":"Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples","volume":"3","author":"Dong","year":"2017","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.xcrm.2025.102423_bib43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/gcc.22847","article-title":"Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments","volume":"59","author":"Wei","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.xcrm.2025.102423_bib44","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102423_bib45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2025.102423_bib46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102423_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102423_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102423_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdu479","article-title":"Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data","volume":"26","author":"Favero","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102423_bib50","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102423_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","article-title":"Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods","volume":"20","author":"Haas","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102423_bib52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102423_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D Graphics Environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"key":"10.1016\/j.xcrm.2025.102423_bib54","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.xcrm.2025.102423_bib55","first-page":"2881","article-title":"Parametric UMAP Embeddings for Representation and Semisupervised Learning","volume":"33","author":"Sainburg","year":"2021","journal-title":"Neural Comput."},{"key":"10.1016\/j.xcrm.2025.102423_bib56","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.xcrm.2025.102423_bib57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jacbts.2022.12.011","article-title":"Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities","volume":"8","author":"Van Norman","year":"2023","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.xcrm.2025.102423_bib58","series-title":"Urinary and Male Genital Tumours","author":"World Health","year":"2022"},{"key":"10.1016\/j.xcrm.2025.102423_bib59","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102423_bib60","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102423_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102423_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep14701","article-title":"An automated fitting procedure and software for dose-response curves with multiphasic features","volume":"5","author":"Di Veroli","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102423_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102423_bib64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","article-title":"Survival analysis part I: basic concepts and first analyses","volume":"89","author":"Clark","year":"2003","journal-title":"Br. J. Cancer"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T20:45:33Z","timestamp":1766177133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666379125004963"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102423","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102423"}}